US$ 27.43
glp-1 employer coverage news october 2025 Among the largest employers (with at least 5,000 workers), 43% now cover GLP -1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their cost for the Who Gets the Shot? GLP-1
Description
Striking the balance: GLP-1/Glucagon Co-Agonism as a treatment strategy for obesity

These actions help keep blood sugar levels under control

In the phase 3 program (SUSTAIN trials for injection, PIONEER for oral): Weekly semaglutide 1.0 mg lowered HbAc by ~1.5% to 1.8% from baseline (e.g

10.1038/aps.2016.21 140 ZubiagaL.BriandO.AugerF.ToucheV.HubertT.ThevenetJ.et al (2023)

GLP-1 receptor signaling pathways
Tirzepatide: A review in type 2 diabetes
